Avidity Biosciences CMO, CHRO Make Large Share Buys and Sells on Sept 15, 2025.

Avidity Biosciences, Inc., a leading RNA company, has recently reported transactions involving two key executives. Chief Medical Officer Hughes Steven George purchased 1,542 shares at $6.57 per share on September 15, 2025, while also selling an identical number of shares at $45.41 per share on the same day. Concurrently, Chief Human Resources Officer McCarthy Teresa acquired 15,000 shares at $22.34 per share on September 15, 2025, and subsequently sold the same number of shares at $41.41 per share on the same day.